BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4898864)

  • 1. [Effect of combined treatment with hydantoinal and cardiac glycosides on the dynamics of left ventricular contraction].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1969 Jul; 43(1):985-9. PubMed ID: 4898864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1969 Oct; 24(40):1523-5. PubMed ID: 5365667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the effect of peruvoside on heart function in animal experiments].
    Schorscher E; Sommer S; Wild AJ; Block A
    Arzneimittelforschung; 1968 Dec; 18(12):1582-90. PubMed ID: 5756257
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 5. [Usefulness of left ventricular contraction period determination by the polygraphic method in the treatment of patients with overt circulatory failure by means of administering cardiac glycosides].
    Smielak-Korombel W
    Pol Tyg Lek; 1976 Sep; 31(38):1641-4. PubMed ID: 980985
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of some intervals constituting ventricular systole during measured work in patients with cardiac insufficiency treated with cardiokinetic drugs].
    Iannetti M; Martini U; Caponnetto S
    Minerva Med; 1966 May; 57(43 Suppl):1991-4. PubMed ID: 5943257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications and contraindications for therapy with cardiac glycosides].
    Haasis R
    Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac glycosides and their use in daily general practice].
    Gaul G
    Med Welt; 1983 Apr; 34(14):452-5. PubMed ID: 6855551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of combined cardiac glycoside and propranolol administration on the dynamics of total left ventricular contraction].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1969 Oct; 43(4):1341-5. PubMed ID: 5355706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the cardiotonic effects of proscilaridine].
    Netto MP; Forti N; Formicola A; Chryssovergis G; Zillioto EE; Campanari JC; Lunardi W; Giannini SD
    Rev Hosp Clin Fac Med Sao Paulo; 1973; 28(6):300-4. PubMed ID: 4767562
    [No Abstract]   [Full Text] [Related]  

  • 11. [Strophanthin-convallatoxol. Clinical comparative double-blind trial].
    Baumgarten G; Beickert A; Berdrow J; Fiehring H; Förster W; Haak W; Hafemeister R; Kiesewetter R; Klein KW; Knappe J; von Knorre G; Krosch H; Lehmann L; Mann D; Menzel B; Noack W; Rösner R; Sundermann A
    Dtsch Gesundheitsw; 1970 May; 25(20):922-6. PubMed ID: 4942748
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of Talusin in the treatment of cardiac insufficiency].
    Grujić M; Perinović M; Ljubojević S
    Med Arh; 1977; 31(3):171-5. PubMed ID: 333198
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical use of a new cardioactive glycoside: proscillaridin A].
    Maiorano G; Arbore S
    Minerva Med; 1967 Dec; 58(96):4243-6. PubMed ID: 6083285
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of cardiac insufficiency with a new cardiac glycoside].
    Becker D
    Landarzt; 1965 Jul; 41(19):831-3. PubMed ID: 5320409
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the cardiac glycosides lanatoside C and strophanthin K on left on left ventricular function in patients with mitral stenosis].
    Dubiel JP; Kolasińska-Kloch W
    Folia Med Cracov; 1982-1983; 24(1-2):25-39. PubMed ID: 7187367
    [No Abstract]   [Full Text] [Related]  

  • 16. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside.
    Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ
    Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593
    [No Abstract]   [Full Text] [Related]  

  • 17. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Actihaemyl as adjuvant in cardiac therapy].
    Lordick H
    Munch Med Wochenschr; 1970 Feb; 112(7):298-300. PubMed ID: 5537795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
    Hansel J
    Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.